下载应用总部位于墨尔本的CSL（CSL）在盈利疲弱和股价承压之下，任命Deborah Waterhouse为首位女性首席执行官。Waterhouse女士将于二月从ViiV Healthcare（ViiV Healthcare）加入，她曾在该公司担任负责人十年。即将卸任的主席Brian McNamee在股东大会上表示，公司所做的并非每个决定都是错误的。CSL报告称，2025/26财年法定净亏损26亿美元，主要由其Vifor（Vifor）业务的资产减值所致。自2024年7月以来，其股价已下跌约70%。
Melbourne-based CSL, under pressure over weak earnings and its share price, has appointed Deborah Waterhouse as its first female chief executive. Ms Waterhouse joins in February from ViiV Healthcare, which she led for 10 years. Outgoing chair Brian McNamee told a shareholders meeting that not every decision the company made was bad. CSL reported a statutory net loss of $US2.6 billion for 2025/26, driven by writedowns in its Vifor business. Its share price has fallen about 70 per cent since July 2024.